Eastman Chemical Co. (EMN) Tops Q2 EPS by 10c; Reaffirms Outlook

Eastman Chemical Co. (NYSE: EMN) reported Q2 EPS of $1.40, $0.10 better than the analyst estimate of $1.30. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.94 billion.

Eastman Chemical Co. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Eastman Chemical Co. (EMN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance